Neuropsychiatric Adverse Events and Oseltamivir for Prophylaxis
- 1 December 2012
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 35 (12) , 1187-1188
- https://doi.org/10.2165/11641690-000000000-00000
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Rethinking credible evidence synthesisBMJ, 2012
- A Pharmacoepidemiologic Study on the Relationship between Neuropsychiatric Symptoms and Therapeutic Drugs after Influenza InfectionJapanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 2010
- Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with OseltamivirDrug Safety, 2008
- Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older PopulationJournal of the American Geriatrics Society, 2001
- Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir for Prophylaxis against InfluenzaKansenshogaku Zasshi, 2000
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999